253 related articles for article (PubMed ID: 34290146)
1. Sulfatides are endogenous ligands for the TLR4-MD-2 complex.
Su L; Athamna M; Wang Y; Wang J; Freudenberg M; Yue T; Wang J; Moresco EMY; He H; Zor T; Beutler B
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34290146
[TBL] [Abstract][Full Text] [Related]
2. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane.
Tanimura N; Saitoh S; Ohto U; Akashi-Takamura S; Fujimoto Y; Fukase K; Shimizu T; Miyake K
Int Immunol; 2014 Jun; 26(6):307-14. PubMed ID: 24380872
[TBL] [Abstract][Full Text] [Related]
3. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
4. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
5. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
6. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
mBio; 2012; 3(4):. PubMed ID: 22872782
[TBL] [Abstract][Full Text] [Related]
8. Myeloid differentiation protein 2 silencing decreases LPS-induced cytokine production and TLR4/MyD88 pathway activity in alveolar macrophages.
Ren W; Hu L; Hua F; Jin J; Wang Y; Zhu L
Immunol Lett; 2011 Dec; 141(1):94-101. PubMed ID: 21849156
[TBL] [Abstract][Full Text] [Related]
9. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Regulatory Acidic Motif as the Determinant of Membrane Localization of TICAM-2.
Funami K; Matsumoto M; Enokizono Y; Ishii N; Tatematsu M; Oshiumi H; Inagaki F; Seya T
J Immunol; 2015 Nov; 195(9):4456-65. PubMed ID: 26408662
[TBL] [Abstract][Full Text] [Related]
11. Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.
Kim S; Kim SY; Pribis JP; Lotze M; Mollen KP; Shapiro R; Loughran P; Scott MJ; Billiar TR
Mol Med; 2013 May; 19(1):88-98. PubMed ID: 23508573
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
Ohto U; Fukase K; Miyake K; Shimizu T
Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
[TBL] [Abstract][Full Text] [Related]
14. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
[TBL] [Abstract][Full Text] [Related]
15. A presumed antagonistic LPS identifies distinct functional organization of TLR4 in mouse microglia.
Döring C; Regen T; Gertig U; van Rossum D; Winkler A; Saiepour N; Brück W; Hanisch UK; Janova H
Glia; 2017 Jul; 65(7):1176-1185. PubMed ID: 28471051
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
17. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
18. TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS.
Wang Y; Su L; Morin MD; Jones BT; Whitby LR; Surakattula MM; Huang H; Shi H; Choi JH; Wang KW; Moresco EM; Berger M; Zhan X; Zhang H; Boger DL; Beutler B
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E884-93. PubMed ID: 26831104
[TBL] [Abstract][Full Text] [Related]
19. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
Bowen WS; Minns LA; Johnson DA; Mitchell TC; Hutton MM; Evans JT
Sci Signal; 2012 Feb; 5(211):ra13. PubMed ID: 22337809
[TBL] [Abstract][Full Text] [Related]
20. Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways.
Liu M; John CM; Jarvis GA
J Immunol; 2010 Dec; 185(11):6974-84. PubMed ID: 21037101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
